Breaking News

Zennova Opens Manufacturing and R&D Center in China

Phase 1 of the multi-dosage formulation center includes 300,000 sq. ft. of manufacturing and R&D space.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Zennova Pharmaceuticals, a Princeton, NJ-based development stage pharmaceutical company focused on complex ophthalmic suspensions and emulsions, hosted a dedication for its manufacturing plant and R&D center on January 11, 2023 in Chengdu, China. The construction of the multi-dosage formulation center signifies completion of a key company milestone in the company’s pathway towards globalization. “The capability to produce high-quality drugs during 2023 will be crucial to long-term growth ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters